C-reactive Protein and Amyloid A as Predictors of Cardiovascular Events in Type 2 Diabetes in CARDS

C-reactive Protein and Amyloid A as Predictors of Cardiovascular Events in Type 2 Diabetes in CARDS

Bibliographic Details
Main Authors:	Charlton-Menys, V, Colhoun, H, Betteridge, D, Soedamah-Muthu, S, Hitman, G, Neil, H, Livingstone, S, Bao, W, DeMicco, D, Preston, G, Fuller, J, Durrington, P, Investigators, CARDS
Format:	Conference item
Published:	2009

Similar Items

Change in Lp-PLA2 With Risk Change on Statin Therapy in the Collaborative Atorvastatin Diabetes Study (CARDS)
by: Betteridge, D, et al.
Published: (2009)

Effects of atorvastatin on kidney outcomes and cardiovascular disease in patients with diabetes: an analysis from the Collaborative Atorvastatin Diabetes Study (CARDS).
by: Colhoun, H, et al.
Published: (2009)

Apolipoproteins, cardiovascular risk and statin response in type 2 diabetes: the Collaborative Atorvastatin Diabetes Study (CARDS).
by: Charlton-Menys, V, et al.
Published: (2009)

Analysis of efficacy and safety in patients aged 65-75 years at randomization: Collaborative Atorvastatin Diabetes Study (CARDS).
by: Neil, H, et al.
Published: (2006)

Targets of statin therapy: LDL cholesterol, non-HDL cholesterol, and apolipoprotein B in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS).
by: Charlton-Menys, V, et al.
Published: (2009)

Effect of atorvastatin in patients 65 years of age with type 2 diabetes: Subgroup analysis from the collaborative atorvastatin diabetes study (CARDS)
by: DeMicco, D, et al.
Published: (2005)

Erratum: Apolipoproteins, cardiovascular risk and statin response in type 2 diabetes: The Collaborative Atorvastatin Diabetes Study (CARDS)
by: Charlton-Menys, V, et al.
Published: (2009)

Total soluble and endogenous secretory receptor for advanced glycation end products as predictive biomarkers of coronary heart disease risk in patients with type 2 diabetes: an analysis from the CARDS trial.
by: Colhoun, H, et al.
Published: (2011)

The effect of atorvastatin therapy on tumour necrosis factor-α and vascular adhesion molecules in patients with type 2 diabetes mellitus with no prior history of coronary heart disease
by: Soedamah-Muthu, S, et al.
Published: (2011)

Effect of atorvastatin on stroke in patients with type 2 diabetes: factors predicting the risk of stroke in the Collaborative Atorvastatin Diabetes Study (CARDS)
by: Hitman, G, et al.
Published: (2005)

Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial.
by: Colhoun, H, et al.
Published: (2004)

Cost-effectiveness of primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes: results from the Collaborative Atorvastatin Diabetes Study (CARDS).
by: Raikou, M, et al.
Published: (2007)

Rapid emergence of effect of atorvastatin on cardiovascular outcomes in the Collaborative Atorvastatin Diabetes Study (CARDS).
by: Colhoun, H, et al.
Published: (2005)

Safety of atorvastatin in the collaborative AtoRvastatin diabetes study (CARDS)
by: Newman, C, et al.
Published: (2006)

The safety and tolerability of atorvastatin 10 mg in the Collaborative Atorvastatin Diabetes Study (CARDS).
by: Newman, C, et al.
Published: (2008)

Stroke prediction and stroke prevention with atorvastatin in the Collaborative Atorvastatin Diabetes Study (CARDS).
by: Hitman, G, et al.
Published: (2007)

Effect of atorvastatin on stroke in the collaborative atorvastatin diabetes study (CARDS): Factors predictive of the risk of stroke
by: Newman, C, et al.
Published: (2005)

Baseline characteristics in the Collaborative AtoRvastatin Diabetes Study (CARDS) in patients with Type 2 diabetes.
by: Thomason, M, et al.
Published: (2004)

Cost-effectiveness of atorvastatin (10mg) in patients with type 2 diabetes without coronary heart disease: CARDS trial analysis and extrapolation
by: Raikou, M, et al.
Published: (2005)

Design of the Collaborative AtoRvastatin Diabetes Study (CARDS) in patients with type 2 diabetes.
by: Colhoun, H, et al.
Published: (2002)

The effect of atorvastatin on serum lipids, lipoproteins and NMR spectroscopy defined lipoprotein subclasses in type 2 diabetic patients with ischaemic heart disease.
by: Soedamah-Muthu, S, et al.
Published: (2003)

Differing predictive relationships between baseline LDL-C, systolic blood pressure, and cardiovascular outcomes
by: Deedwania, PC, et al.
Published: (2016)

Increased C-reactive protein levels in overweight and obese women taking exogenous hormones: the United Kingdom Women's Heart Study (UKWHS).
by: Kwok, S, et al.
Published: (2009)

Status report of lipid-lowering trials in diabetes.
by: Betteridge, D, et al.
Published: (2000)

ALA rules filing catalog cards /
by: American Library Association. Editorial Committee. Subcommittee on the ALA Rules for Filing Catalogue Cards, et al.
Published: (1968)

Comparison of the risk of fatal coronary heart disease in treated xanthomatous and non-xanthomatous heterozygous familial hypercholesterolaemia: a prospective registry study.
by: Neil, H, et al.
Published: (2003)

Non-coronary heart disease mortality and risk of fatal cancer in patients with treated heterozygous familial hypercholesterolaemia: a prospective registry study.
by: Neil, H, et al.
Published: (2005)

Alstrom syndrome (OMIM 203800): a case report and literature review
by: Hegele Robert A, et al.
Published: (2007-12-01)

Mycobacterium tuberculosis CarD, an essential global transcriptional regulator forms amyloid-like fibrils
by: Kaur, G, et al.
Published: (2018)

Character Building at Bachelor's Psychology Program: Findings Based on a Natural Approach
by: Sabita Soedamah-Muthu, et al.
Published: (2023-06-01)

Reactive oxygen and oxidative stress tolerance in plant pathogenic Pseudomonas
by: Fones, H, et al.
Published: (2012)

Reactive oxygen and oxidative stress tolerance in plant pathogenic Pseudomonas.
by: Fones, H, et al.
Published: (2012)

All-cause and cardiovascular mortality in treated patients with severe hypertriglyceridaemia: A long-term prospective registry study.
by: Neil, H, et al.
Published: (2010)

Cortical superficial siderosis is associated with reactive astrogliosis in cerebral amyloid angiopathy
by: Corinne A. Auger, et al.
Published: (2023-08-01)

The relation between C-reactive protein and serum amyloid A in patients with autoinflammatory diseases
by: G. E. Legger, et al.
Published: (2022-11-01)

Established and emerging coronary risk factors in patients with heterozygous familial hypercholesterolaemia.
by: Neil, H, et al.
Published: (2004)

Established and emerging coronary risk factors in patients with heterozygous familial hypercholesterolaemia
by: Neil, H, et al.
Published: (2003)

Red Card for the Red Card
by: Maximilian Steinbeis

A gene variant near ATM is significantly associated with metformin treatment response in type 2 diabetes: a replication and meta-analysis of five cohorts.
by: van Leeuwen, N, et al.
Published: (2012)

A gene variant near ATM is significantly associated with metformin treatment response in type 2 diabetes: a replication and meta-analysis of five cohorts
by: van Leeuwen, N, et al.
Published: (2012)